Biomarkers of injury to neural tissue in veterinary medicine

1. Adami C., Sorci G., Blasi E., Agneletti A.L., Bistoni F., Donato R.: S100B expression in and effects on microglia. Glia 2001, 33, 131–142.10.1002/1098-1136(200102)33:2<131::AID-GLIA1012>3.0.CO;2-DSearch in Google Scholar

2. Agoston D.V., Kamnaksh A.: Frontiers in neuroengineering modeling the neurobehavioral consequences of blast-induced traumatic brain injury spectrum disorder and identifying related biomarkers. In: Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects, edited by Kobeissy F.H., Taylor & Francis, Boca Raton, USA, 2015.Search in Google Scholar

3. Andersson F.I., Werrell E.F., McMorran L., Crone W.J., Das C., Hsu S.T., Jackson S.E.: The effect of Parkinson's-disease-associated mutations on the deubiquitinating enzyme UCH-L1. J Mol Biol 2011, 407, 261–272.10.1016/j.jmb.2010.12.029Search in Google Scholar

4. Arnaoutakis G.J., George T.J., Wang K.K., Wilson M.A., Allen J.G., Robinson C.W., Haggerty K.A., Weiss E.S., Blue M.E., Talbot C.C., Jr., Troncoso J.C., Johnston M.V., Baumgartner W.A.: Serum levels of neuron-specific ubiquitin carboxyl-terminal esterase-L1 predict brain injury in a canine model of hypothermic circulatory arrest. J Thorac Cardioc Sur 2011, 142, 902–910.10.1016/j.jtcvs.2011.06.027Search in Google Scholar

5. Babcock L., Byczkowski T., Wade S.L., Ho M., Bazarian J.J.: Inability of S100B to predict postconcussion syndrome in children who present to the emergency department with mild traumatic brain injury: a brief report. Pediatr Emerg Care 2013, 29, 458–461.10.1097/PEC.0b013e31828a202dSearch in Google Scholar

6. Bandyopadhyay S., Hennes H., Gorelick M.H., Wells R.G., Walsh-Kelly C.M.: Serum neuron-specific enolase as a predictor of short-term outcome in children with closed traumatic brain injury. Acad Emerg Med 2005, 12, 732–738.10.1197/j.aem.2005.02.017Search in Google Scholar

7. Berger R.P., Hayes R.L., Richichi R., Beers S.R., Wang K.K.: Serum concentrations of ubiquitin C-terminal hydrolase-L1 and alphaII-spectrin breakdown product 145 kDa correlate with outcome after pediatric TBI. J Neurotraum 2012, 29, 162–167.10.1089/neu.2011.1989Search in Google Scholar

8. Blomme E.A., Waring J.F..: Cerebrospinal fluid biomarkers: exploiting advances in humans to improve veterinary care. Vet J 2013, 197, 113–114.10.1016/j.tvjl.2013.04.026Search in Google Scholar

9. Blyth B.J., Farahvar A., He H., Nayak A., Yang C., Shaw G., Bazarian J.J.: Elevated serum ubiquitin carboxy-terminal hydrolase L1 is associated with abnormal blood-brain barrier function after traumatic brain injury. J Neurotraum 2011, 28, 2453–2462.10.1089/neu.2010.1653Search in Google Scholar

10. Boggs J.M., Homchaudhuri L., Ranagaraj G., Liu Y., Smith G.S., Harauz G.: Interaction of myelin basic protein with cytoskeletal and signaling proteins in cultured primary oligodendrocytes and N19 oligodendroglial cells. BMC Res Notes 2014, 7, 387.10.1186/1756-0500-7-387Search in Google Scholar

11. Boggs J.M., Rangaraj G.: Interaction of lipid-bound myelin basic protein with actin filaments and calmodulin. Biochemistry 2000, 39, 7799–7806.10.1021/bi0002129Search in Google Scholar

12. Buil-Bruna N., Lopez-Picazo J.M., Moreno-Jimenez M., Martin-Algarra S., Ribba B., Troconiz I.F.: A population pharmacodynamic model for lactate dehydrogenase and neuron specific enolase to predict tumor progression in small cell lung cancer patients. AAPS J 2014, 16, 609–619.10.1208/s12248-014-9600-0401204824740245Search in Google Scholar

13. Cao F., Yang Xf., Liu Wg., Hu Ww., Li G., Zheng Xj., Shen F., Zhao Xq., Lv St.: Elevation of neuron-specific enolase and S-100β protein level in experimental acute spinal cord injury. J Clin Neurosci 2008, 15, 541–544.10.1016/j.jocn.2007.05.01418343116Search in Google Scholar

14. Cruzana B.C., Hondo E., Kitamura N., Matsuzaki S., Nakagawa M., Yamada J.: Differential localization of immunoreactive alpha- and beta-subunits of S-100 protein in feline testis. Anat Histol Embryol 2000, 29, 83–86.10.1046/j.1439-0264.2000.00235.x10932384Search in Google Scholar

15. D'Aversa T.G., Eugenin E.A., Lopez L., Berman J.W.: Myelin basic protein induces inflammatory mediators from primary human endothelial cells and blood-brain barrier disruption: implications for the pathogenesis of multiple sclerosis. Neuropathol Appl Neurobiol 2013, 39, 270–283.10.1111/j.1365-2990.2012.01279.x343081822524708Search in Google Scholar

16. Diaz-Arrastia R., Wang K.K., Papa L., Sorani M.D., Yue J.K., Puccio A.M., McMahon P.J., Inoue T., Yuh E.L., Lingsma H.F., Maas A.I., Valadka A.B., Okonkwo D.O., Manley G.T.: Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein. J Neurotraum 2014, 31, 19–25.10.1089/neu.2013.3040388009023865516Search in Google Scholar

17. Donato R.: Intracellular and extracellular roles of S100 proteins. Microscop Res Tech 2003, 60, 540–551. Douglas-Escobar M., Yang C., Bennett J., Shuster J., Theriaque D., Leibovici A., Kays D., Zheng T., Rossignol C., Shaw G., Weiss MD.: A pilot study of novel biomarkers in neonates with hypoxic-ischemic encephalopathy. Pediatr Res 2010, 68, 531–536.10.1203/PDR.0b013e3181f85a03385101120736881Search in Google Scholar

18. El-Maraghi S., Yehia H., Hossam H., Yehia A., Mowafy H.: The prognostic value of neuron specific enolase in head injury. Egypt J Crit Care Med 2013, 1, 25–32.10.1016/j.ejccm.2012.12.002Search in Google Scholar

19. Eng L.F., Ghirnikar R.S., Lee Y.L.: Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem Res 2000, 25, 1439–1451.10.1023/A:1007677003387Search in Google Scholar

20. Fisher R.S., van Emde Boas W., Blume W., Elger C., Genton P., Lee P., Engel J. Jr.: Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2004, 46, 470–472.10.1111/j.0013-9580.2005.66104.x15816939Search in Google Scholar

21. Foerch C., Pfeilschifter W., Zeiner P., Brunkhorst R.: Glial fibrillary acidic protein in patients with symptoms of acute stroke: diagnostic marker of cerebral hemorrhage. Nervenarzt 2014, 85, 982–989.10.1007/s00115-014-4128-125057113Search in Google Scholar

22. Gonçalves C.A., Leite M.C., Guerra M.C.: Adipocytes as an important source of serum S100B and possible roles of this protein in adipose tissue. Cardiovasc Psychiatry Neurol 2010, Article ID 790431.10.1155/2010/790431Search in Google Scholar

23. Goyal R., Mathur S.K., Gupta S., Goyal R., Kumar S., Batra A., Hasija S., Sen R.: Immunohistochemical expression of glial fibrillary acidic protein and CAM5.2 in glial tumors and their role in differentiating glial tumors from metastatic tumors of central nervous system. J Neurosci Rural Pract 2015, 6, 499–503.10.4103/0976-3147.168426Search in Google Scholar

24. Hayakawa K., Okazaki R., Ishii K., Ueno T., Izawa N., Tanaka Y., Toyooka S., Matsuoka N., Morioka K., Ohori Y., Nakamura K., Akai M., Tobimatsu Y., Hamabe Y., Ogata T.: Phosphorylated neurofilament subunit NF-H as a biomarker for evaluating the severity of spinal cord injury patients, a pilot study. Spinal Cord 2012, 50, 493–496.10.1038/sc.2011.184Search in Google Scholar

25. Head E., Moffat K., Das P., Sarsoza F., Poon W.W., Landsberg G., Cotman C.W., Murphy M.P.: Beta-amyloid deposition and tau phosphorylation in clinically characterized aged cats. Neurobiol Aging 2005, 26, 749–763.10.1016/j.neurobiolaging.2004.06.015Search in Google Scholar

26. Hu Y-Y., He S-S., Wang X-C., Duan Q-H., Khatoon S., Iqbal K., Grundke-Iqbal I., Wang J-Z.: Elevated levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patients. Neurosci Lett 2002, 320, 156–160.10.1016/S0304-3940(02)00047-2Search in Google Scholar

27. Huh J.W., Laurer H.L., Raghupathi R., Helfaer M.A., Saatman K.E.: Rapid loss and partial recovery of neurofilament immunostaining following focal brain injury in mice. Exp Neurol 2002, 175, 198–208.10.1006/exnr.2002.7880Search in Google Scholar

28. Ide T., Uchida K., Kikuta F., Suzuki K., Nakayama H.: Immunohistochemical characterization of canine neuroepithelial tumors. Vet Pathol 2010, 47, 741–750.10.1177/0300985810363486Search in Google Scholar

29. Jany P.L., Hagemann T.L., Messing A.: GFAP expression as an indicator of disease severity in mouse models of Alexander disease. ASN Neuro 2013, 5, e00109.10.1042/AN20130003Search in Google Scholar

30. Kamchatov P.R., Ruleva N., Dugin S.F., Buriachkovskaia L.I., Chugunov A.V., Mikhailova N.A., Basse D.A.: Neurospecific proteins and autoantibodies in serum of patients with acute ischemic stroke. Zh Nevrol Psikhiatr Im S S Korsakova 2009, 109, 69–72.Search in Google Scholar

31. Karkela J., Bock E., Kaukinen S.: CSF and serum brain-specific creatine kinase isoenzyme (CK-BB), neuron-specific enolase (NSE) and neural cell adhesion molecule (NCAM) as prognostic markers for hypoxic brain injury after cardiac arrest in man. J Neurol Sci 1993, 116, 100–109.10.1016/0022-510X(93)90095-GSearch in Google Scholar

32. Levine G.J., Levine J.M., Witsberger T.H., Kerwin S.C., Russell K.E., Suchodolski J., Steiner J., Fosgate G.T.: Cerebrospinal fluid myelin basic protein as a prognostic biomarker in dogs with thoracolumbar intervertebral disk herniation. J Vet Intern Med 2010, 24, 890–896.10.1111/j.1939-1676.2010.0531.x20492479Search in Google Scholar

33. Li Y., Wang Z., Zhang B., Zhe X., Wang M., Bai J., Lin T., Zhang S.: Cerebrospinal fluid ubiquitin C-terminal hydrolase as a novel marker of neuronal damage after epileptic seizure. Epilepsy Res 2013, 103, 205–210.10.1016/j.eplepsyres.2012.08.001Search in Google Scholar

34. Mandelkow E.M., Mandelkow E.: Biochemistry and cell biology of tau protein in neurofibrillary degeneration. Cold Spring Harb Perspect Med 2012, 2, a006247.10.1101/cshperspect.a006247Search in Google Scholar

35. Matsuki N., Takahashi M., Yaegashi M., Tamahara S., Ono K.: Serial examinations of anti-GFAP autoantibodies in cerebrospinal fluids in canine necrotizing meningoencephalitis. J Vet Med Sci 2009, 71, 99–100.10.1292/jvms.71.99Search in Google Scholar

36. Mayer C.A., Brunkhorst R., Niessner M., Pfeilschifter W., Steinmetz H., Foerch C.: Blood levels of glial fibrillary acidic protein (GFAP) in patients with neurological diseases. PloS One 2013, 8, e62101.10.1371/journal.pone.0062101Search in Google Scholar

37. Mecocci P., Parnetti L., Donato R., Santucci C., Santucci A., Cadini D., Foa E., Cecchetti R., Senin U.: Serum autoantibodies against glial fibrillary acidic protein in brain aging and senile dementias. Brain Behav Immun 1992, 6, 286–292.10.1016/0889-1591(92)90049-TSearch in Google Scholar

38. Michetti F., Corvino V., Geloso M.C., Lattanzi W., Bernardini C., Serpero L., Gazzolo D.: The S100B protein in biological fluids: more than a lifelong biomarker of brain distress. J Neurochem 2012, 120, 644–659.10.1111/j.1471-4159.2011.07612.x22145907Search in Google Scholar

39. Missler U., Wiesmann M., Wittmann G., Magerkurth O., Hagenstrom H.: Measurement of glial fibrillary acidic protein in human blood: analytical method and preliminary clinical results. Clin Chem 1999, 45, 138–141.10.1093/clinchem/45.1.138Search in Google Scholar

40. Mondello S., Palmio J., Streeter J., Hayes R.L., Peltola J., Jeromin A.: Ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) is increased in cerebrospinal fluid and plasma of patients after epileptic seizure. BMC Neurol 2012, 12: 85.10.1186/1471-2377-12-85350020722931063Search in Google Scholar

41. Mondello S., Robicsek S.A., Gabrielli A., Brophy G.M., Papa L., Tepas J., Robertson C., Buki A., Scharf D., Jixiang M., Akinyi L., Muller U., Wang K.K., Hayes R.L.: Alpha II-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients. J Neurotraum 2010, 27, 1203–1213.10.1089/neu.2010.1278294290420408766Search in Google Scholar

42. Nishida H., Nakayama M., Tanaka H., Kamishina H., Izawa T., Hatoya S., Sugiura K., Suzuki Y., Ide C., Inaba T.: Evaluation of serum phosphorylated neurofilament subunit NF-H as a prognostic biomarker in dogs with thoracolumbar intervertebral disc herniation. Vet Surg 2012, 43, 289–293.10.1111/j.1532-950X.2014.12144.x24467275Search in Google Scholar

43. Oji T., Kamishina H., Cheeseman J.A., Clemmons R.M.: Measurement of myelin basic protein in the cerebrospinal fluid of dogs with degenerative myelopathy. Vet Clin Pathol 2007, 36, 281–284.10.1111/j.1939-165X.2007.tb00225.xSearch in Google Scholar

44. Osaka H., Wang Y.L., Takada K., Takizawa S., Setsuie R., Li H., Sato Y., Nishikawa K., Sun Y.J., Sakurai M., Harada T., Hara Y., Kimura I., Chiba S., Namikawa K., Kiyama H., Noda M., Aoki S., Wada K.: Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron. Hum Mol Genet 2003, 12, 1945–1958.10.1093/hmg/ddg21112913066Search in Google Scholar

45. Paltrinieri S., Cazzaniga S., da Cunha N.P., Giordano A.: Electrophoretic fractionation of creatine kinase isoenzymes and macroenzymes in clinically healthy dogs and cats and preliminary evaluation in central neurologic disease. Vet Clin Pathol 2010, 39, 329–336.10.1111/j.1939-165X.2010.00242.x716926020698943Search in Google Scholar

46. Pancholi V.: Multifunctional alpha-enolase: its role in diseases. Cell Mol Life Sci 2001, 58, 902–920.10.1007/PL0000091011497239Search in Google Scholar

47. Papa L., Lewis L.M., Falk J.L., Zhang Z., Silvestri S., Giordano P., Brophy G.M., Demery J.A., Dixit N.K., Ferguson I., Liu M.C., Mo J., Akinyi L., Schmid K., Mondello S., Robertson C.S., Tortella F.C., Hayes R.L., Wang K.K.: Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention. Ann Emerg Med 2012, 59, 471–483.10.1016/j.annemergmed.2011.08.021383097722071014Search in Google Scholar

48. Papa L., Silvestri S., Brophy G.M., Giordano P., Falk J.L., Braga C.F., Tan C.N., Ameli N.J., Demery J.A., Dixit N.K., Mendes M.E., Hayes R.L., Wang K.K., Robertson C.S.: GFAP out-performs S100beta in detecting traumatic intracranial lesions on computed tomography in trauma patients with mild traumatic brain injury and those with extracranial lesions. J Neurotraum 2014, 31, 1815–1822.10.1089/neu.2013.3245422405124903744Search in Google Scholar

49. Patro N., Naik A.A., Patro I.: Differential temporal expression of S100β in developing rat brain. Front Cell Neurosci 2015, doi: 10.3389/fncel.2015.00087.10.3389/fncel.2015.00087436424825852479Search in Google Scholar

50. Pelinka L.E., Hertz H., Mauritz W., Harada N., Jafarmadar M., Albrecht M., Redl H., Bahrami S.: Nonspecific increase of systemic neuron-specific enolase after trauma: clinical and experimental findings. Shock 2005, 24, 119–123.10.1097/01.shk.0000168876.68154.4316044081Search in Google Scholar

51. Petzold A.: CSF biomarkers for improved prognostic accuracy in acute CNS disease. Neurol Res 2007, 29, 691–708.10.1179/016164107X24008018173909Search in Google Scholar

52. Petzold A., Keir G., Warren J., Fox N., Rossor M.N.: A systematic review and meta-analysis of CSF neurofilament protein levels as biomarkers in dementia. Neurodegener Dis 2007, 4, 185–194.10.1159/00010184317596713Search in Google Scholar

53. Petzold A., Shaw G.: Comparison of two ELISA methods for measuring levels of the phosphorylated neurofilament heavy chain. J Immunol Methods 2007, 319, 34–40.10.1016/j.jim.2006.09.021Search in Google Scholar

54. Pike B.R., Flint J., Dutta S., Johnson E., Wang K.K., Hayes R.L.: Accumulation of non-erythroid alpha II-spectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats. J Neurochem 2001, 78, 1297–1306.10.1046/j.1471-4159.2001.00510.xSearch in Google Scholar

55. Poletaev A.B., Morozov S.G., Gnedenko B.B., Zlunikin V.M., Korzhenevskey D.A.: Serum anti-S100b, anti-GFAP and anti-NGF autoantibodies of IgG class in healthy persons and patients with mental and neurological disorders. Autoimmunity 2000, 32, 33–38.10.3109/08916930008995985Search in Google Scholar

56. Pugliese M., Mascort J., Mahy N., Ferrer I.: Diffuse beta-amyloid plaques and hyperphosphorylated tau are unrelated processes in aged dogs with behavioral deficits. Acta Neuropathol 2006, 112, 175–183.10.1007/s00401-006-0087-3Search in Google Scholar

57. Riederer B.M., Binder L.I.: Differential distribution of tau proteins in developing cat cerebellum. Brain Res Bull 1994, 33, 155–161.10.1016/0361-9230(94)90245-3Search in Google Scholar

58. Roerig A., Carlson R., Tipold A., Stein V.M.: Cerebrospinal fluid tau protein as a biomarker for severity of spinal cord injury in dogs with intervertebral disc herniation. Vet J 2013, 197, 253–258.10.1016/j.tvjl.2013.02.00523499240Search in Google Scholar

59. Sandler S.J., Figaji A.A., Adelson P.D.: Clinical applications of biomarkers in pediatric traumatic brain injury. Childs Nerv Syst 2010, 26, 205–213.10.1007/s00381-009-1009-119902222Search in Google Scholar

60. Sato Y., Shimamura S., Mashita T., Kobayashi S., Okamura Y., Katayama M., Kamishina H., Sato R., Uzuka Y., Yasuda J.: Serum glial fibrillary acidic protein as a diagnostic biomarker in dogs with progressive myelomalacia. J Vet Med Sci 2013, 75, 949–953.10.1292/jvms.12-048323470323Search in Google Scholar

61. Sawashima Y., Sawashima K., Taura Y., Shimada A., Umemura T.: Clinical and pathological findings of a Yorkshire terrier affected with necrotizing encephalitis. J Vet Med Sci 1996, 58, 659–661.10.1292/jvms.58.6598844603Search in Google Scholar

62. Selakovic V., Raicevic R., Radenovic L.: The increase of neuron-specific enolase in cerebrospinal fluid and plasma as a marker of neuronal damage in patients with acute brain infarction. J Clin Neurosci 2005, 12, 542–547.10.1016/j.jocn.2004.07.01915921910Search in Google Scholar

63. Sergeant N., Delacourte A., Buée L.: Tau protein as a differential biomarker of tauopathies. Biochim Biophys Acta 2005, 1739, 179–197.10.1016/j.bbadis.2004.06.020Search in Google Scholar

64. Shaw G., Yang C., Ellis R., Anderson K., Parker Mickle J., Scheff S., Pike B., Anderson D.K., Howland D.R.: Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury. Biochem Biophys Rec Commun 2005, 336, 1268–1277.10.1016/j.bbrc.2005.08.252Search in Google Scholar

65. Shibuya M., Matsuki N., Fujiwara K., Imajoh-Ohmi S., Fukuda H., Pham N.T., Tamahara S., Ono K.: Autoantibodies against glial fibrillary acidic protein (GFAP) in cerebrospinal fluids from Pug dogs with necrotizing meningoencephalitis. J Vet Med Sci 2007, 69, 241–245.10.1292/jvms.69.241Search in Google Scholar

66. Skogseid I.M., Nordby H.K., Urdal P., Paus E., Lilleaas F.: Increased serum creatine kinase BB and neuron specific enolase following head injury indicates brain damage. Acta Neurochir 1992, 115, 106–111.10.1007/BF01406367Search in Google Scholar

67. Smith S.H., Van Winkle T.: Cerebral vascular hamartomas in five dogs. Vet Pathol 2001, 38, 108–112.10.1354/vp.38-1-108Search in Google Scholar

68. Stein D.M., Lindell A.L., Murdock K.R., Kufera J.A., Menaker J., Bochicchio G.V., Aarabi B., Scalea T.M.: Use of serum biomarkers to predict cerebral hypoxia after severe traumatic brain injury. J Neurotrauma 2012, 29, 1140–114.10.1089/neu.2011.2149Search in Google Scholar

69. Steiner J., Bernstein H.G., Bielau H., Berndt A., Brisch R., Mawrin C., Keilhoff G., Bogerts B.: Evidence for a wide extra-astrocytic distribution of S100B in human brain. BMC Neurosci 2007, 8: 2.10.1186/1471-2202-8-2Search in Google Scholar

70. Summers B.A., Whitaker J.N., Appel M.J.: Demyelinating canine distemper encephalomyelitis: measurement of myelin basic protein in cerebrospinal fluid. J Neuroimmunol 1987, 14, 227–233.10.1016/0165-5728(87)90057-9Search in Google Scholar

71. Takala R.S., Posti J.P., Runtti H., Newcombe V.F., Outtrim J., Katila A.J., Frantzen J., Ala-Seppala H., Kyllonen A., Maanpaa H.R., Tallus J., Hossain M.I., Coles J.P., Hutchinson P., van Gils M., Menon D.K., Tenovuo O.: GFAP and UCH-L1 as outcome predictors in traumatic brain injury. World Neurosurg 2016, 87, 8–20.10.1016/j.wneu.2015.10.06626547005Search in Google Scholar

72. Toda Y., Matsuki N., Shibuya M., Fujioka I., Tamahara S., Ono K.: Glial fibrillary acidic protein (GFAP) and anti-GFAP autoantibody in canine necrotising meningoencephalitis. Vet Rec 2007, 161, 261–264.10.1136/vr.161.8.26117720962Search in Google Scholar

73. Usui A., Kato K., Murase M., Hotta T., Tanaka M., Takeuchi E., Abe T.: Neural tissue-related proteins (NSE, G0 alpha, 28-kDa calbindin-D, S100b and CK-BB) in serum and cerebrospinal fluid after cardiac arrest. J Neurol Sci 1994, 123, 134–139.10.1016/0022-510X(94)90215-1Search in Google Scholar

74. Van Eldik L.J., Wainwright M.S.: The Janus face of glial-derived S100B: beneficial and detrimental functions in the brain. Restor Neurol Neurosci 2003, 21, 97–108.Search in Google Scholar

75. Visser I.J., Vermeulen D.J., Vellema P., Gruys E.: Total CK and CK-BB activity in serum from sheep with scrapie. Vet Q 1992, 14, 157–158.10.1080/01652176.1992.96943561485407Search in Google Scholar

76. Wang Q., Wang Z., Zhu P., Jiang J.: Alterations of myelin basic protein and ultrastructure in the limbic system at the early stage of trauma-related stress disorder in dogs. J Trauma 2004, 56, 604–610.10.1097/01.TA.0000058122.57737.0E15128132Search in Google Scholar

77. Weiss E.S., Wang K.K., Allen J.G., Blue M.E., Nwakanma L.U., Liu M.C., Lange M.S., Berrong J., Wilson M.A., Gott V.L., Troncoso J.C., Hayes R.L., Johnston M.V., Baumgartner W.A.: Alpha II-spectrin breakdown products serve as novel markers of brain injury severity in a canine model of hypothermic circulatory arrest. Ann Thorac Surg 2009, 88, 543–550.10.1016/j.athoracsur.2009.04.016341240419632410Search in Google Scholar

78. Williams D.R.: Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau. Intern Med J 2006, 36, 652–660.10.1111/j.1445-5994.2006.01153.x16958643Search in Google Scholar

79. Yokobori S., Zhang Z., Moghieb A., Mondello S., Gajavelli S., Dietrich W.D., Bramlett H., Hayes R.L., Wang M., Wang K.K., Bullock M.R.: Acute diagnostic biomarkers for spinal cord injury: review of the literature and preliminary research report. World Neurosurg 2015, 83, 867–878.10.1016/j.wneu.2013.03.01223524031Search in Google Scholar

80. Zetterberg M., Sjolander A., von Otter M., Palmer M.S., Landgren S., Minthon L., Wallin A., Andreasen N., Blennow K., Zetterberg H.: Ubiquitin carboxy-terminal hydrolase L1 (UCHL1) S18Y polymorphism in Alzheimer's disease. Mol Neurodegener 2010, 5: 11.10.1186/1750-1326-5-11284822520302621Search in Google Scholar

81. Zuchero J.B., Fu M.M., Sloan S.A., Ibrahim A., Olson A., Zaremba A., Dugas J.C., Wienbar S., Caprariello A.V., Kantor C., Leonoudakis D., Lariosa-Willingham K., Kronenberg G., Gertz K., Soderling S.H., Miller R.H., Barres B.A.: CNS myelin wrapping is driven by actin disassembly. Dev Cell 2015, 34, 152–167.10.1016/j.devcel.2015.06.011451936826166300Search in Google Scholar